Trademarkia Logo

Australia

AU$
DERMATOX
Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Aquavit Pharmaceuticals, Inc.

3753 Howard Hughes Parkway,

2nd Floor, UNITED STATES OF AMERICA

Serial Number

2198134 filed on 21 May 2021

Correspondent

Daniel J. Nevrivy Nevrivy Patent Law Group P.L.L.C.

1000 Potomac Street NW,,

Suite 200,

UNITED STATES OF AMERICA

DERMATOX

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diseases of the central nervous system, dystonia, blepharospasm and spasmodic torticollis, spasticity Read More

Mark Details


Serial Number

2198134

Registered On

NA

Renewal On

NA

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
12th Feb 2025Status change to Voided
11th Jan 2024Amendment to International Registration Contact Requested
17th Jan 2023International Registration in Australia Refused correspondence sent
16th Jan 2023Status change to Lapsed/Not Protected
30th Jul 2022IRDA - Opposition Still Possible Notice correspondence sent
6th Oct 2021Adverse Report (Examination) correspondence sent
5th Oct 2021IP Right has been Examined
30th Jul 2021Awaiting examination
29th Jul 2021IP Right Filed Published
29th Jul 2021Status change to Published